Autologous DC/AML Fusion Vaccine-primed T-cells

**Semantic type:** Cell|Pharmacologic Substance

**Definition:** A preparation of autologous T-lymphocytes primed with autologous dendritic cell (DC)/acute myeloid leukemia (AML) fusion vaccine, with potential immunomodulating and antineoplastic activities. Upon reintroduction into the patient, autologous DC/AML fusion vaccine-primed T-cells specifically target and kill tumor cells expressing AML-associated antigens.

**Synonyms:** - Autologous DC/AML Fusion Vaccine-primed T Cells - Autologous DC/AML Fusion Vaccine-primed T-lymphocytes - Autologous DC/AML Primed T Cells - Autologous DC/AML Vaccine Primed T Cells - Autologous Dendritic Cell/Acute Myeloid Leukemia Fusion Vaccine-primed T-cells